Holen Sie sich die Stockscreener-App
27.53
4.84%
-1.40
Finanzdaten der Celldex Therapeutics Inc-Aktie (CLDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
46.67%
0.022
|
0.015 | 0.121 | - | 0.73 |
| Research and Development |
7.48%
67.54
|
73.00 | - | - | - |
| Costs And Expenses |
4.51%
80.64
|
84.45 | 87.27 | 73.62 | 64.59 |
| Operating Income/Loss |
4.51%
-80.62
|
-84.44 | -87.15 | -73.62 | -63.86 |
Net Income/Loss
|
6.59%
-73.50
|
-78.69 | -81.32 | -67.04 | -56.60 |
| Basic Average Shares |
16.94%
77.84
|
66.57 | 66.36 | 0.0664 | 0.0664 |
| Diluted Average Shares |
16.94%
77.84
|
66.57 | 66.36 | 0.0664 | 0.0664 |
| Basic Earnings Per Share |
20.34%
-0.94
|
-1.18 | -1.23 | -1.01 | -0.85 |
| Diluted Earnings Per Share |
20.34%
-0.94
|
-1.18 | -1.23 | -1.01 | -0.85 |
2.71%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):